Atlas Trials

The Effect of Ketamine on Attentiveness

Clinical trial NCT01165294 · COMPLETED

Trial details

NCT number
NCT01165294
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.